Target Price | $228.59 |
Price | $234.75 |
Deviation | 2.62% |
Number of Estimates | 17 |
17 Analysts have issued a price target IBM 2025 . The average IBM target price is $228.59. This is 2.62% lower than the current stock price. The highest price target is $260.00 10.76% , the lowest is $150.00 36.10% . | |
A rating was issued by 22 analysts: 10 Analysts recommend IBM to buy, 8 to hold and 4 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the IBM stock has an average upside potential 2025 of 2.62% . Most analysts recommend the IBM stock at Purchase. |
15 Analysts have issued a sales forecast IBM 2024 . The average IBM sales estimate is $62.8b . This is 0.39% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $62.9b 0.55% , the lowest is $62.7b 0.25% .
This results in the following potential growth metrics:
2023 | $61.9b | 2.20% |
---|---|---|
2024 | $62.8b | 1.56% |
2025 | $65.9b | 4.84% |
2026 | $68.4b | 3.92% |
2027 | $73.3b | 7.06% |
2028 | $77.5b | 5.83% |
10 Analysts have issued an IBM EBITDA forecast 2024. The average IBM EBITDA estimate is $16.0b . This is 2.83% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $18.3b 17.67% , the lowest is $14.3b 8.32% .
This results in the following potential growth metrics and future EBITDA Margins:
2023 | $14.9b | 18.54% |
---|---|---|
2024 | $16.0b | 7.33% |
2025 | $16.5b | 3.05% |
2026 | $17.2b | 4.41% |
2027 | $16.1b | 6.23% |
2028 | $16.8b | 4.36% |
2023 | 24.09% | 15.99% |
---|---|---|
2024 | 25.45% | 5.67% |
2025 | 25.02% | 1.69% |
2026 | 25.14% | 0.48% |
2027 | 22.02% | 12.41% |
2028 | 21.71% | 1.41% |
6 IBM Analysts have issued a net profit forecast 2024. The average IBM net profit estimate is $6.7b . This is 4.78% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $8.2b 29.26% , the lowest is $6.2b 2.04% .
This results in the following potential growth metrics and future Net Margins:
2023 | $7.5b | 352.22% |
---|---|---|
2024 | $6.7b | 11.57% |
2025 | $8.6b | 29.64% |
2026 | $9.1b | 5.66% |
2027 | $10.1b | 10.75% |
2028 | $10.9b | 7.97% |
2023 | 12.17% | 342.50% |
---|---|---|
2024 | 10.59% | 12.96% |
2025 | 13.10% | 23.70% |
2026 | 13.32% | 1.68% |
2027 | 13.78% | 3.45% |
2028 | 14.06% | 2.03% |
6 Analysts have issued a IBM forecast for earnings per share. The average IBM <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is $7.20 . This is 4.80% higher than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is $8.88 29.26% , the lowest is $6.73 2.04% .
This results in the following potential growth metrics and future valuations:
2023 | $8.14 | 352.22% |
---|---|---|
2024 | $7.20 | 11.55% |
2025 | $9.33 | 29.58% |
2026 | $9.86 | 5.68% |
2027 | $10.92 | 10.75% |
2028 | $11.79 | 7.97% |
Current | 34.17 | 60.42% |
---|---|---|
2024 | 32.61 | 4.57% |
2025 | 25.16 | 22.85% |
2026 | 23.81 | 5.37% |
2027 | 21.50 | 9.70% |
2028 | 19.91 | 7.40% |
Based on analysts' sales estimates for 2024, the IBM stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of 4.20 and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of 3.46 .
This results in the following potential growth metrics and future valuations:
Current | 4.21 | 32.81% |
---|---|---|
2024 | 4.20 | 0.35% |
2025 | 4.00 | 4.61% |
2026 | 3.85 | 3.77% |
2027 | 3.60 | 6.59% |
2028 | 3.40 | 5.51% |
Current | 3.47 | 44.72% |
---|---|---|
2024 | 3.46 | 0.39% |
2025 | 3.30 | 4.61% |
2026 | 3.17 | 3.77% |
2027 | 2.96 | 6.59% |
2028 | 2.80 | 5.51% |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.